{"symbol":"BMY","fiscalQuarter":"Q4-2013","reportDate":"2014-01-24","reportTime":"BMO","status":"reported","company":{"name":"Bristol-Myers Squibb Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BMY/earnings/Q4-2013","postBrief":{"headline":"Bristol-Myers Squibb Beats on EPS, Stock Down 5.58%","keyNumbers":[{"metric":"EPS","actual":"$0.51","expected":"N/A","surprise":"+19.44%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"Bristol-Myers Squibb reported better-than-expected earnings per share, which was a positive surprise. However, the stock dropped by 5.58% in reaction to the earnings report, indicating that investors may have had concerns about other aspects of the company's performance or future outlook.","metaDescription":"Bristol-Myers Squibb (BMY) Q4 2013 earnings: EPS beat by 19.44%. Stock down 5.58%. Full breakdown."}}